Application 018768
- Type
- NDA
- Sponsor
- CORDEN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VEPESID | ETOPOSIDE | INJECTABLE;INJECTION | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018768-001 | VEPESID | ETOPOSIDE | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1983-11-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N018768-001 | VEPESID | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD | 1983-11-10 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ETOPOSIDE | ETOPOSIDE | Onesource Specialty Pharma Limited | 7bc994df-ee84-4ed7-80fa-737f70918953 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Fresenius Kabi USA, LLC | fe870629-104d-4d67-a7c6-f53bc588121e | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Avopef | ETOPOSIDE | Avyxa Pharma, LLC | acc1e443-ef7b-486f-a638-710a20e81059 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | BluePoint Laboratories | 0dddbe44-b4f4-431f-9011-8a54abbd4cbf | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| VePesid | ETOPOSIDE | Amneal Pharmaceuticals NY LLC | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | VePesid ETOPOSIDE |
| Etoposide | ETOPOSIDE | Meitheal Pharmaceuticals Inc. | 50491106-dddd-4efd-bd83-060e7947a244 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Accord Healthcare Inc. | 4f850eb2-3542-43a0-90e8-bb37fa05cf15 | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Hikma Pharmaceuticals USA Inc. | e0cd61b9-2375-4e3d-a610-d87dad962468 | 2024-09-05 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Hikma Pharmaceuticals USA Inc. | 6dfedeff-a807-4405-a482-2f7109ad31c9 | 2023-09-14 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | BluePoint Laboratories | 157d4e0f-806d-4011-9dec-97e2449e507b | 2018-06-20 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Mylan Pharmaceuticals Inc. | 508a418e-985f-4208-9324-2230655bb5c2 | 2016-04-19 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |